Evidence map›Paper›PMID 42474705›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Multiscale Spatial Fusion Feature-Driven Characterization of Gastric Cancer Invasive Margins: A Multicenter Cohort Study for Preoperative Accurate Differentiation Between T4a and T4b Subtypes.

Guoliang Zheng, Xiaomiao Chai, Peng Jin, Xin Xin, Yingjie Li, Chun Yang, Jia Wei, Zishuo Yan, Jingyu Zhang, Qianning Zhao and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Guoliang ZhengDepartment of Gastric Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.ORCID https://orcid.org/0000-0002-4905-5120
Xiaomiao ChaiSchool of Pharmacy, China Medical University, Shenyang, Liaoning, China.
Peng JinDepartment of Gastric Surgery, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0001-8179-6191
Xin XinShenyang Mental Health Center, Shenyang, Liaoning, China.
Yingjie LiDepartment of Radiology, Hunnan Central Hospital, Shenyang, Liaoning, China.
Chun YangSchool of Pharmacy, China Medical University, Shenyang, Liaoning, China.
Jia WeiSchool of Pharmacy, China Medical University, Shenyang, Liaoning, China.
Zishuo YanSchool of Pharmacy, China Medical University, Shenyang, Liaoning, China.
Jingyu ZhangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Qianning ZhaoSchool of Management, Hebei University, Baoding, Hebei, China.
Yingchen HanDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Ning ZhangDepartment of Pathology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Fuze LiDepartment of Gastric Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Bo QiaoDepartment of Gastric Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Huan WangDepartment of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, China.ORCID https://orcid.org/0009-0007-2031-4612
Huachuan ZhengCenter of Translational Medicine and Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Yan LiDepartment of Laboratory Medicine, Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Xin ZhangDepartment of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Yan ZhaoDepartment of Gastric Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Wenjun MaoDepartment of Thoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.ORCID https://orcid.org/0000-0002-4644-9749
Jing ZhangSchool of Pharmacy, China Medical University, Shenyang, Liaoning, China.

Funding

Liaoning Province Science and Technology Joint Plan 2023JH2/101700195Liaoning Provincial Natural Science Foundation 2024-MS-264Liaoning Provincial Natural Science Foundation 2024-MS-269Tianjin Key Medical Discipline Construction Project TJYXZDXK-3-003ATianjin Science and Technology Major Project and Engineering, Public Health Youth Project 25ZXWQSY00060
6 · The paper itself

Abstract

Accurate preoperative differentiation of gastric cancer T4a/b stages is crucial for surgical planning and prognosis. However, conventional CT assessments often yield suboptimal staging accuracy due to visual limitations and inadequate peritumoral microinvasion quantification. This study developed a multi-scale spatial feature fusion model based on extended regions of interest (eROI) for precise preoperative T4a/b differentiation. We proposed the GAVR model with a three-tier architecture: a Boundary-Augmented U-Net for eROI generation incorporating the peritumoral microenvironment; parallel pathways extracting conventional radiomics, 2D, and 3D deep learning features; and a Vision Transformer for global attention-weighted fusion and discriminative representation learning. The model was validated across a multicenter cohort of 1804 patients, including internal, external, and prospective sets. A blinded reader study involving 16 radiologists evaluated its clinical utility. GAVR demonstrated exceptional generalizability, achieving AUCs of 0.987 and 0.979 in two independent external sets and 0.987 prospectively. Ablation studies confirmed the necessity of multi-scale features. GAVR assistance significantly improved radiologists' diagnostic accuracy (0.609 to 0.795) and reduced reading time by 60%. By deeply fusing multi-scale spatial features, GAVR characterizes structural heterogeneity in complex gastric cancer invasive margins and mitigates overfitting. It demonstrates clear translational value as an embeddable decision-support tool for multidisciplinary gastric cancer management.

Indexed as

Margins of ExcisionStomach NeoplasmsTomography, X-Ray ComputedAgedCohort StudiesDeep LearningFemaleHumansMaleMiddle AgedNeoplasm StagingProspective StudiesRadiomicscomputed tomographydeep learninggastric cancermulticenter studysemantic segmentationT stagingvisual transformer

Identifiers

PMID42474705
PMCPMC13384034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.